SWS Hemodialysis Care Co., Ltd. (SHA:688410)

SWS Hemodialysis Care Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	594.28	567.1	689.96	381.89	283.1	254.27
Other Revenue	0.18	0.18	0.15	0.12	0.17	0.14
Revenue	594.45	567.27	690.11	382.01	283.28	254.41
Revenue Growth (YoY)	-9.82%	-17.80%	80.65%	34.86%	11.35%	78.78%
Cost of Revenue	329.63	320.46	354.38	217.09	168.83	147.92
Gross Profit	264.83	246.81	335.73	164.93	114.44	106.49
Selling, General & Admin	159.82	157.6	132.21	97.7	80.34	75.62
Research & Development	58.24	54.24	37.67	23.13	17.74	17.12
Other Operating Expenses	4.61	4.55	-17.35	-8.68	-4.77	-4.29
Operating Expenses	221.09	214.65	155.93	115.29	95.22	89.3
Operating Income	43.74	32.16	179.8	49.64	19.23	17.19
Interest Expense	-0.36	-0.28	-0.16	-0.8	-1.61	-2.93
Interest & Investment Income	20.65	25.56	25.72	2.61	4.8	0.51
Currency Exchange Gain (Loss)	0.93	0.93	0.68	0.74	-0.2	-0.35
Other Non Operating Income (Expenses)	-0.54	-0.58	2.67	-1.05	-0.74	-0.09
EBT Excluding Unusual Items	64.41	57.79	208.71	51.14	21.48	14.34
Gain (Loss) on Sale of Investments	8.47	9.14	10.79	0.78	-	0.03
Gain (Loss) on Sale of Assets	-0.28	-0.28	0.45	-0.34	0.04	-0.18
Asset Writedown	-5.45	-8.01	-	-	-0.05	-0.15
Other Unusual Items	5.74	9.78	-	11.77	0.59	6.98
Pretax Income	72.88	68.42	219.95	63.36	22.05	21.02
Income Tax Expense	5.55	4.42	27.74	6.46	3.91	2.68
Earnings From Continuing Operations	67.33	64	192.21	56.9	18.14	18.33
Minority Interest in Earnings	6.33	6.89	2.29	2.33	1.33	2.28
Net Income	73.66	70.89	194.5	59.24	19.47	20.62
Net Income to Common	73.66	70.89	194.5	59.24	19.47	20.62
Net Income Growth	-52.21%	-63.55%	228.34%	204.20%	-5.55%	-
Shares Outstanding (Basic)	319	320	321	321	241	218
Shares Outstanding (Diluted)	319	320	321	321	241	218
Shares Change (YoY)	-0.73%	-0.49%	0.03%	33.29%	10.47%	2.05%
EPS (Basic)	0.23	0.22	0.61	0.18	0.08	0.09
EPS (Diluted)	0.23	0.22	0.61	0.18	0.08	0.09
EPS Growth	-51.86%	-63.37%	228.25%	128.22%	-14.50%	-
Free Cash Flow	42.3	59.97	-47.97	232.9	4.69	-41.51
Free Cash Flow Per Share	0.13	0.19	-0.15	0.72	0.02	-0.19
Dividend Per Share	0.100	0.100	0.269	-	-	-
Dividend Growth	-62.76%	-62.76%	-	-	-	-
Gross Margin	44.55%	43.51%	48.65%	43.17%	40.40%	41.86%
Operating Margin	7.36%	5.67%	26.05%	13.00%	6.79%	6.76%
Profit Margin	12.39%	12.50%	28.18%	15.51%	6.87%	8.10%
Free Cash Flow Margin	7.12%	10.57%	-6.95%	60.97%	1.65%	-16.31%
EBITDA	63.09	50.88	196.03	63.94	32.99	28.72
EBITDA Margin	10.61%	8.97%	28.41%	16.74%	11.65%	11.29%
D&A For EBITDA	19.35	18.73	16.23	14.3	13.76	11.53
EBIT	43.74	32.16	179.8	49.64	19.23	17.19
EBIT Margin	7.36%	5.67%	26.05%	13.00%	6.79%	6.76%
Effective Tax Rate	7.62%	6.46%	12.61%	10.19%	17.72%	12.77%
Revenue as Reported	594.45	567.27	690.11	382.01	283.28	254.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.